Torren Management’s OptimizeRx OPRX Stock Holding History

Torren Management’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-97	Closed	-$1.19K	–	1303
2025 Q4	$1.19K	Buy	+97	New	+$1.58K	﹤0.01%	1166

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Torren Management's OPRX Position: Q1 2026 in Review

Torren Management sold out of OptimizeRx (OPRX) in Q1 2026, closing a stake of 97 shares — an estimated $1.19K sold.

Torren Management first reported a position in OPRX in Q4 2025 and held it in 1 quarter. The position peaked at $1.19K in Q4 2025. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

Torren Management reported no remaining OptimizeRx position as of Q1 2026 after selling out during the quarter.
Torren Management sold 97 OptimizeRx shares in Q1 2026, an estimated $1.19K.
Torren Management first reported a position in OptimizeRx in Q4 2025 and held it in 1 quarter.
Torren Management's OptimizeRx position peaked at $1.19K in Q4 2025.
127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.